Page: case-studies
Signigene will be present at the 2025 ESPT conference in Rotterdam from the 5-8th of Nov. Please contact us to connect at info@signigene.com
SigniGene is proud to announce a new partnership integrating our Pharmacogenomics As A Service platform with two leading healthcare providers in the United Kingdom. Together with NPH group and Hurdle we worked hard to establish a seamless click-to-guidelines solution bringing the benefits of genetically-driven pharmacology to the workplace.
Signigene delivers PAAS to healthcare providers.
NPH Group bespoke personal health solutions for the workplace.
Hurdle diagnostic infrastructure for healthcare solutions.

We are proud to announce that we have obtained the UK Conformance Assessed (UKCA) Mark from the Medicines and Healthcare products Regulatory Agency (MHRA).
SigniGene will be attending the Insurance Innovators Summit on the 15th and 16th of November 2023.
We have made SigniGene available as an application on several platforms, just go to SigniGene and click on the button at the bottom of the screen to download and install it.
SigniGene will be present at the PGx conference in London 21st of June, 2023.
In a world-wide first we have established interoperability with Electronic Health Record providers that adhered to the openEHR standards, allowing Pharmacogenomic based advice to be shared with patients and medical professionals around the world. In particular we can automatically upload PGX advice from Signigene to any EHRServer and Better Care portal.
SigniGene will be present at the PGx conference in London 15th of June, 2022.
Attendance of the U-PGx conference 30-31st of March, 2022.
Scan this code with an authenticator app, such as Authy or Google Authenticator, preferably on a different device, then type in the access code it shows below and click OK to check it has been set up correctly. Then save your profile and then when you sign in you will be prompted for an access code, open your authenticator to get the current value and type it in.